The U.S. Anti-Obesity Drugs Market is projected to grow from USD 2.27 Billion in 2025 to USD 19.64 Billion by 2035, while Europe is expected to expand from USD 1.88 Billion to USD 16.94 Billion, supported by increasing GLP-1 therapy adoption, broader reimbursement coverage, and obesity treatment innovation.
The U.S. Anti-Obesity Drugs Market is projected to grow from USD 2.27 Billion in 2025 to USD 19.64 Billion by 2035, while Europe is expected to expand from USD 1.88 Billion to USD 16.94 Billion, supported by increasing GLP-1 therapy adoption, broader reimbursement coverage, and obesity treatment innovation.